News for Viemed Healthcare, Inc. (VMD.TO)

We came across a bullish thesis on Viemed Healthcare, Inc. (VMD) on Substack by Petty Cash. In this article, we will summarize the bulls’ thesis on VMD. Viemed Healthcare, Inc.

On March 14, 2025, Timothy Smokoff, a Director at Viemed Healthcare Inc (VMD), sold 11,865 shares of the company. Following this transaction, the insider now ow

Revenue Growth: 20% increase year-over-year for Q4; 23% increase for the full year 2024.Vent Revenue: 4.4% sequential increase in Q4; accounted for 55% of Q4 r

Mar 11, 2025 / 03:00PM GMTOperator Greetings and welcome to the Viemed Healthcare year-end 2024 earnings call. (Operator Instructions) Please note that this con

Viemed Healthcare, Inc. (NASDAQ:VMD) Q4 2024 Earnings Conference Call March 11, 2025 11:00 AM ETCompany ParticipantsTodd Zehnder - COOTrae Fitzgerald -...

LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the ”œCompany” or ”œViemed”) (VMD), a national leader in respiratory care an

**media[549743]**

LAFAYETTE, La., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the ”œCompany” or ”œViemed”) (VMD), a national leader in respiratory care and

U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Friday. Shares of Ingles Markets, Incorporated IMKTA fell in t...

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining around 0.2% points on Monday. Shares of Super Micro Computer, Inc. SMCI f...

We came across a bullish thesis on Viemed Healthcare, Inc. (VMD) on Substack by Petty Cash. In this article, we will summarize the bulls’ thesis on VMD. Viemed Healthcare, Inc.

Viemed Healthcare, Inc. (NASDAQ:VMD) Q3 2024 Results Conference Call November 7, 2024 12:00 PM ETCompany ParticipantsTodd Zehnder - Chief Operating...

Net Revenue: $58 million, a company record for the third quarter.Sequential Revenue Growth: 6% increase from the previous quarter.Year-over-Year Revenue Growth

Nov 07, 2024 / 05:00PM GMTOperator Greetings and welcome to Vmed's third quarter, 2024 earnings conference call. At this time, all participants are on a listen-

Viemed Healthcare Inc (TSX:VMD) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $0, and the earnings are ex

Net Revenue: $55 million for Q2 2024, a 27% increase from Q2 2023.Gross Margin: 60% for the quarter.EBITDA Margin: 23% for the quarter.Gross Profit: $32.9 mill

Aug 08, 2024 / 03:00PM GMTOperator Good day, ladies and gentlemen, and welcome to the VieMed second-quarter 2024 earnings call. Our host for today's call is Tod

Viemed Healthcare's strong revenue growth, growing patient numbers, and bullish technicals to rally shares higher. Learn why NVMD stock is a Buy.

American Oncology is a healthcare stock with potential growth. See here to know why we believe AONC stock is a speculative buy.